Electrocardiographic and Echocardiographic Predictors of Atrial Fibrillation in Patients With Hypertrophic

Leonard Mandeş1,2, Monica Roşca1,2, Daniela Ciupercă1

  • 1Cardiology Department, University of Medicine and Pharmacy "Carol Davila"- Euroecolab, Bucharest, Romania.

Insights

Hypertrophic cardiomyopathy patients at risk for atrial fibrillation can be identified by left atrial booster pump function (ASr) and electrical dispersion (P wave dispersion - Pd). These measures predict AF incidence, even when left atrial size appears normal.

Area of Science:

  • Cardiology
  • Electrophysiology
  • Cardiac Imaging

Background:

  • Hypertrophic cardiomyopathy (HCM) patients exhibit a higher prevalence of atrial fibrillation (AF) than the general population.
  • Left atrial (LA) remodeling is a known risk factor for AF development in HCM.
  • Assessing LA structure and function is crucial for predicting AF risk in HCM.

Purpose of the Study:

  • To evaluate the predictive value of LA electrocardiographic and echocardiographic parameters for incident AF in HCM patients.
  • To determine if LA functional and electrical parameters are superior to structural parameters in predicting AF risk.

Main Methods:

  • Prospective, monocentric study of 126 HCM patients in sinus rhythm.
  • Median follow-up of 56 months, with AF incidence recorded.
  • Multivariable analysis including LA booster pump function (ASr), P wave dispersion (Pd), LA diameter, and LA volume.

Main Results:

  • 30.9% of patients developed new-onset AF during follow-up.
  • LA booster pump function (ASr) and P wave dispersion (Pd) were independent predictors of incident AF.
  • LA structural parameters (diameter, volume) did not predict AF, even in patients with small LA size (<45 mm).
  • P wave dispersion (Pd) accurately predicted AF in patients with small LA size (AUC = 0.89).

Conclusions:

  • LA booster pump function (ASr) and electrical dispersion (Pd) are key predictors of incident AF in HCM patients.
  • These parameters offer improved risk stratification for AF, particularly in patients with normal LA dimensions.
  • Electrical dispersion (Pd) is a valuable tool for identifying AF risk in HCM patients with small LA size.
Abstract

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
45
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias01:25

ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias

Arrhythmia is a condition characterized by an irregular heart rhythm, with ECG changes that differ based on its origin and nature. The types of arrhythmias discussed below include atrial, junctional, and ventricular arrhythmias.Atrial ArrhythmiasPremature Atrial Complexes (PACs): PACs are early atrial beats caused by stress, caffeine, alcohol, electrolyte imbalances, hypoxia, hyperthyroidism, or certain medications (e.g., bronchodilators and decongestants). The ECG shows early P waves with an...
159
Dysrhythmias V: Evaluating Dysrhythmias01:30

Dysrhythmias V: Evaluating Dysrhythmias

Dysrhythmias, also known as arrhythmias, are disturbances in the heart's rhythm that range from benign to life-threatening. A thorough evaluation is crucial for appropriate management and involves a comprehensive medical history, physical examination, and various diagnostic tests.Medical HistorySymptoms: Collect detailed information on palpitations, dizziness, syncope, chest pain, and fatigue. Note their onset, frequency, and triggers.Previous Cardiac Issues: Document any history of heart...
117
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
52
Aortic Regurgitation II: Clinical Features and Diagnostic Tests01:22

Aortic Regurgitation II: Clinical Features and Diagnostic Tests

Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
51
Electrocardiogram01:29

Electrocardiogram

An electrocardiogram (ECG or EKG) is a critical diagnostic tool that records the electrical signals produced by the heart during each heartbeat. This recording is achieved through electrodes placed strategically on the arms, legs, and chest. The electrocardiograph amplifies these signals and produces 12 distinct tracings, offering a comprehensive understanding of the heart's electrical activity.
Three major waveforms are present in a typical ECG recording: the P wave, the QRS complex, and...
3.2K